Titan Pharmaceuticals
TTNP
C$5.54
Share price
-8.22%
Change (1 day)
-29.89%
Change (1 year)
Categories
Titan Pharmaceuticals (TTNP) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : C$0.38 Million
According to Titan Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.38 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Titan Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | C$1.91 M | -47.63% |
| 2022-12-31 | C$3.65 M | 0.47% |
| 2021-12-31 | C$3.63 M | -37.33% |
| 2020-12-31 | C$5.8 M | -45.03% |
| 2019-12-31 | C$10.56 M | 6.77% |
| 2018-12-31 | C$9.89 M | -2.21% |
| 2017-12-31 | C$10.11 M | 37.5% |
| 2016-12-31 | C$7.35 M | -15.76% |
| 2015-12-31 | C$8.73 M | -38.5% |
| 2014-12-31 | C$14.2 M | 5.37% |
| 2013-12-31 | C$13.47 M | -71.73% |
| 2012-12-31 | C$47.68 M | 54.74% |
| 2011-12-31 | C$30.81 M | 185.33% |
| 2010-12-31 | C$10.8 M | 160.99% |
| 2009-12-31 | C$4.13 M | |
| 2007-12-31 | C$4.24 M | 7.44% |
| 2006-12-31 | C$3.95 M | 8.23% |
| 2005-12-31 | C$3.65 M | -17.22% |
| 2004-12-31 | C$4.41 M | 1.76% |
| 2003-12-31 | C$4.33 M | -30.44% |
| 2002-12-31 | C$6.23 M | -32.14% |
| 2001-12-31 | C$9.18 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Vanda Pharmaceuticals VNDA | C$0.16 B | 43,096.77% | 🇺🇸 USA |
 MediciNova MNOV | C$3.44 M | 796.30% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | C$50.24 M | 12,978.85% | 🇺🇸 USA |
 Johnson & Johnson JNJ | C$159.11 B | 41,419,971.68% | 🇺🇸 USA |
 Novartis NVS | C$84.66 B | 22,038,968.10% | 🇨🇭 Switzerland |
 Repligen
RGEN | C$1.19 B | 310,530.82% | 🇺🇸 USA |